BNCM, Soon-to-be Delex Healthcare Group, Confirms Aggressive Global Growth Strategy After Merger

Bounce Mobile Systems Inc. (OTC: BNCM), which is transitioning to become Delex Healthcare Group Inc., today provided investors with a strategic update on its operational growth and market expansion following the successful merger with DELEX Healthcare Group, Inc., which shall act as the main entity responsible for DELEX Pharma International, Inc. (Delex Pharma), with the purpose of aligning its operations to facilitate strategic growth.

The strategic integration leverages BNCM's public market platform with DELEX’s robust and rapidly growing healthcare operations, positioning the combined entity as a dominant force in specialized pharmaceuticals and advanced medical device distribution, particularly across the Philippines and the wider Southeast Asian region.

Strategic and Operational Highlights

Delex Pharma, already ranking as the third-largest national company in the Philippine hospital channel market (according to IQVIA), has significantly accelerated its business expansion, driven by three key strategic pillars:

1. Aggressive Product Portfolio Expansion:

• Pharmaceutical Growth: The company successfully launched 11 new pharmaceutical products in the first half of 2024, targeting high-need therapeutic areas including Critical Care (e.g., Betalex for hypertensive emergencies), Oncology (e.g., Docelex, Paclitex), Anesthesia, and Anti-infectives. This expansion is projected to contribute an additional 20% to Delex Pharma’s total revenue for 2024.

• Oncology Focus: This rapid growth is reinforced by the strategic entry into the oncology sector, providing cost-effective and high-quality medicines to combat rising cancer prevalence.

2. Bolstered Medical Device Business Unit (BU):

• The Medical Device BU is rapidly expanding and is expected to contribute 30% to the company's total revenue going forward.

• This growth is fueled by strategic partnerships with leading global medical technology companies, including SternMed GmbH (advanced surgical and anesthesia units) and Masimo/Verathon (next-generation patient monitoring and airway visualization systems), ensuring high-quality, innovative solutions are available across critical care units nationwide.

3. Enhanced Market Reach and Global Vision:

• The company is executing a massive retail footprint expansion, planning to increase its network of Delex Pharmacy stores from 3 to 60 locations, dramatically enhancing direct-to-consumer distribution across the Philippines.

• The combined entity is jointly evaluating entry points into high-growth international healthcare markets, with a strategic focus on expanding its pharmaceutical franchise and distribution channels across Asia.

• Management has unveiled a multi-phase plan to integrate digital health technologies, with an active M&A pipeline targeting segments like AI diagnostics and telehealth to solidify its market leadership and drive long-term value.

Management Commentary

“The merger of BNCM and Delex Healthcare Group marks a transformative milestone in our shared pursuit of building a fully integrated, high-growth healthcare platform,” said J. de Ruyter Oroceo, Chairman of the Board of DLX Holdings, the parent company of Delex Pharma International, Inc., and concurrently Chairman of the Board and Chief Executive Officer of Delex Pharma International, Inc.

This strategic union harnesses BNCM’s operational capabilities and DELEX’s proven strength in product innovation and international partnerships—demonstrating the immense scalability and potential of this new structure. We are not merely expanding our portfolio; we are redefining access to critical care, medical devices, and pharmaceuticals. Together, BNCM and Delex Healthcare Group are creating sustainable value for our stakeholders and elevating the standards of healthcare delivery across the region.

About Bounce Mobile Systems, Inc. (BNCM)

On July 2^nd. In 2024, the Board of Directors of Bounce Mobile Systems Inc. (BNCM) and Delex Healthcare Group Inc. (DELEX) signed an agreement for the merger between DELEX and BNCM. 

About Delex Healthcare Group Inc. (DELEX)

DELEX is a leading pharmaceutical company in the Philippines, engaged in the development, marketing, and distribution of a wide range of pharmaceutical and healthcare products. DELEX is committed to providing quality and affordable medicines and medical devices, with a strong focus on critical care, anti-infectives, anesthesia, oncology, and women's health.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are based on the current expectations and beliefs of management and are subject to risks and uncertainties. Investors are cautioned that actual results may differ materially from those projected. The statements regarding expected revenue contribution, expansion of pharmacy stores, and international market entry are forward-looking and subject to change.